Vaccinogen produces personalized treatments that use the patient's immune system to fight the disease.
Vaccinogen produces personalized treatments that use the patient's immune system to fight the disease.
Vaccinogen is dedicated to reducing cancer recurrence using personalized treatments designed to help each patient’s immune system identify and destroy residual tumor cells after surgery.
OncoVAX® is an autologous cancer treatment manufactured with a patented process to leverage a patient’s own tumor cells to launch a potent and customized immune response.
Vaccinogen seeks to parter with investors to bring to market the first commercializable, personal cellular therapy for treating an unmet medical need in late stage colon cancer and in combinatorial studies with advanced cancers